Loading data
CHGGNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 376.91 m USD | 617.57 m USD | 716.3 m USD | 766.9 m USD | 776.27 m USD |
| Cost of revenue | 152.15 m USD | 180.93 m USD | 225.94 m USD | 197.4 m USD | 254.9 m USD |
| Gross profit | 224.76 m USD | 436.65 m USD | 490.35 m USD | 569.5 m USD | 521.36 m USD |
| Research and development expense | 93.45 m USD | 170.43 m USD | 191.71 m USD | 196.64 m USD | 178.82 m USD |
| Operating profit | -116.86 m USD | -737.11 m USD | -67.73 m USD | 8.96 m USD | 78.11 m USD |
| Profit before tax | -100.14 m USD | -688.37 m USD | 50.31 m USD | 103.95 m USD | 5.74 m USD |
| Income tax expense | 3.28 m USD | 148.7 m USD | 32.13 m USD | -162.69 m USD | 7.2 m USD |
| Net income (reported basis) | -103 m USD | -837 m USD | 18 m USD | 266.64 m USD | -1.46 m USD |
| Basic earnings per share | -0.96 USD/share | -8.1 USD/share | 0.16 USD/share | 2.09 USD/share | -0.01 USD/share |
| Diluted earnings per share | -0.96 USD/share | -8.1 USD/share | -0.34 USD/share | 1.34 USD/share | -0.01 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.